Omnia SanaPlant Comparison
Wormwood vs Oregon Grape
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Wormwood and Oregon Grape: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Wormwood | Oregon Grape | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 7/10 | Stronger for Oregon Grape |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Infection (general) | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 7/10 | Stronger for Oregon Grape |
| Skin irritation | 1/10 | 8/10 | Stronger for Oregon Grape |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Intensely bitter sesquiterpene lactones responsible for the classic digestive-bitter action.
Volatile oil containing thujone (alpha- and beta-isomers), the neurotoxic ketone that limits safe internal use, along with other monoterpenes.
Antioxidant constituents contributing to the plant's antioxidant activity.
Pharmacological Actions
Artemisia absinthium (wormwood) total flavonoids and its constituent alpha/beta-thujone induce ROS- and caspase-mediated apoptosis in cervical and choriocarcinoma cancer cells (preclinical).
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
Artemisia absinthium (wormwood) total flavonoids (cynaroside, astragalin) inhibit HeLa cervical cancer cells via ROS-mediated apoptosis, and its terpenoid alpha,beta-thujone induces caspase-dependent apoptosis in choriocarcinoma cells and sensitizes them to paclitaxel (preclinical).
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antidiabetic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
Topical for atopic dermatitis (eczema) and skin irritation
Antimicrobial (berberine) - supports skin and mucosal infection
inferred from anti-inflammatory action
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis); Topical treatment of mild-to-moderate psoriasis (reduces plaque severity) - a double-blind, placebo-controlled RCT showed significant improvement in PASI and quality-of-life scores
Topical for atopic dermatitis (eczema) and skin irritation
Safety, Cautions & Contraindications
CAUTION: Contains thujone, which is neurotoxic in significant amounts. Internal use should be limited in duration and dose — short-term use only (under 4 weeks). Contraindicated in pregnancy (powerful uterine stimulant). Avoid in epilepsy, renal disease, and in children. The small amounts present in properly prepared bitter tinctures and vermouth are generally considered safe. The thujone content of absinthe was historically exaggerated.
Duke (2002) rates wormwood as + (use with caution) and provides clinical evidence (score 2) for use as an aperitif and bitter digestive tonic, consistent with Commission E approval for dyspeptic complaints and loss of appetite. The plant contains absinthin and artabsin (bitter sesquiterpene lactones) responsible for digestive stimulation, and also thujone — a neurotoxic ketone that is the active agent responsible for 'absinthism' (historical neurological syndrome linked to absinthe consumption). Duke strongly cautions that thujone content limits safe long-term use, and wormwood should not be taken internally for more than 4 weeks at a time. Strictly contraindicated in pregnancy (abortifacient, neurotoxic) and epilepsy (Duke, 2002).
Avoid internal use in pregnancy and breastfeeding: like goldenseal, the berberine it contains can cross the placenta and into milk and worsen newborn jaundice (kernicterus risk).
External Ids
Botanical Description
Aromatic, silvery-grey perennial herb with finely divided, silky-hairy leaves and numerous small, pale yellow, drooping, globe-shaped flower heads borne in loose branched panicles. The whole plant has a characteristic intensely bitter taste and a pungent, sage-like aroma.[4]
Evergreen shrub, 0.5-2 m tall, spreading by underground rhizomes to form thickets. The pinnate leaves resemble holly, with 5-9 glossy, dark green, spiny-toothed leaflets that often turn bronze-red in winter. Small, bright yellow, six-petalled flowers are borne in dense, upright terminal racemes in early spring, followed by clusters of blue-black, grape-like berries with a waxy bloom. The wood and inner bark of the stem and root are bright yellow when cut, owing to their high content of berberine-type alkaloids.
Habitat
Grows on dry, sunny, stony or waste ground, roadsides and field margins; native to Europe, North Africa and temperate Asia, and naturalised in North America.[4]
Native to the Pacific Northwest of North America, growing in coniferous woodland understorey, forest margins and rocky slopes; widely introduced and naturalised as an ornamental and hedging shrub in temperate regions elsewhere.
Harvesting
The flowering aerial parts (leaf, stem and flower) are cut as flowering begins, in mid- to late summer, and dried in a warm, shaded, airy place.[4]
The root and root bark, the medicinal parts, are dug from established plants - traditionally in autumn - and dried. Because wild populations are slow-growing, cultivated or nursery-sourced material is preferred over wild-harvesting.
Traditional Uses
Oregon grape root has a traditional Native American and Eclectic-medicine history as a bitter tonic and alterative (blood-purifying) remedy and for skin conditions. Its main modern use, supported by clinical trials, is topical application of a standardised bark extract for mild-to-moderate psoriasis and atopic dermatitis (eczema), where its berberine-type alkaloids give anti-inflammatory and antiproliferative effects on skin cells.[1, 11, 12]
Preparations
Dried flowering herb infused briefly in hot water as a very bitter digestive tea, taken before meals to stimulate appetite.
Dosage
Because of its thujone content, traditional herbal references limit internal use to small bitter doses (around 0.5-1 g dried herb per cup) for no more than about 4 weeks at a time. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Batiha, G.E.S., Olatunde, A., El-Mleeh, A., Hetta, H.F., Al-Rejaie, S. et al (2020) 'Bioactive Compounds, Pharmacological Actions, and Pharmacokinetics of Wormwood (Artemisia absinthium)', Antibiotics (Basel), 9(6), pp. 353. doi:10.3390/antibiotics9060353 Traditional / reference
https://doi.org/10.3390/antibiotics9060353 - Wubuli, A., Abdulla, R., Zhao, J., Wu, T. and Aisa, H.A (2024) 'Exploring anti-inflammatory and antioxidant-related quality markers of Artemisia absinthium L. based on spectrum-effect relationship', Phytochemical Analysis, 35(5), pp. 1152-1173. doi:10.1002/pca.3350 Preclinical
https://doi.org/10.1002/pca.3350 - Rashidi, R., Akaberi, M., Gholoobi, A., Ghazavi, H. and Forouzanfar, F (2023) 'Artemisia absinthium Extract Attenuates the Quinolinic Acid-Induced Cell Injury in OLN-93 Cells', Current Drug Discovery Technologies, 20(4), pp. e300323215213. doi:10.2174/1570163820666230330105331 Preclinical
https://doi.org/10.2174/1570163820666230330105331 - Szopa, A., Pajor, J., Klin, P., Rzepiela, A., Elansary, H.O., Al-Mana, F.A., Mattar, M.A. and Ekiert, H (2020) 'Artemisia absinthium L. - Importance in the History of Medicine, the Latest Advances in Phytochemistry and Therapeutical, Cosmetological and Culinary Uses', Plants, 9(9), pp. 1063. doi:10.3390/plants9091063 Meta-analysis / review
https://doi.org/10.3390/plants9091063 - Hbika, A., Daoudi, N.E., Bouyanzer, A., Bouhrim, M., Mohti, H., Loukili, E.H., Mechchate, H., Al-Salahi, R., Nasr, F.A., Bnouham, M. and Zaid, A (2022) 'Artemisia absinthium L. Aqueous and Ethyl Acetate Extracts: Antioxidant Effect and Potential Activity In Vitro and In Vivo against Pancreatic alpha-Amylase and Intestinal alpha-Glucosidase', Pharmaceutics, 14(3), pp. 481. doi:10.3390/pharmaceutics14030481 Preclinical
https://doi.org/10.3390/pharmaceutics14030481 - Bagheri, F., Amri, J., Salehi, M., Karami, H., Alimoradian, A. and Latifi, S.A (2020) 'Effect of Artemisia absinthium ethanolic extract on oxidative stress markers and the TLR4, S100A4, Bax and Bcl-2 genes expression in the kidney of STZ-induced diabetic rats', Hormone Molecular Biology and Clinical Investigation, 41(4), pp. 20200028. doi:10.1515/hmbci-2020-0028 Preclinical
https://doi.org/10.1515/hmbci-2020-0028 - Al-Malki, A.L (2018) 'Shikimic acid from Artemisia absinthium inhibits protein glycation in diabetic rats', International Journal of Biological Macromolecules, 122, pp. 1212-1216. doi:10.1016/j.ijbiomac.2018.09.072 Preclinical
https://doi.org/10.1016/j.ijbiomac.2018.09.072 - Boeing, T., de Souza, J., Vilhena da Silva, R.C., Mariano, L.N.B., Mota da Silva, L., Gerhardt, G.M., Cretton, S., Klein-Junior, L.C. and de Souza, P (2023) 'Gastroprotective effect of Artemisia absinthium L.: A medicinal plant used in the treatment of digestive disorders', Journal of Ethnopharmacology, 312, pp. 116488. doi:10.1016/j.jep.2023.116488 Preclinical
https://doi.org/10.1016/j.jep.2023.116488 - Liu, Z., Li, X., Jin, Y., Nan, T., Zhao, Y., Huang, L. and Yuan, Y (2023) 'New Evidence for Artemisia absinthium as an Alternative to Classical Antibiotics: Chemical Analysis of Phenolic Compounds, Screening for Antimicrobial Activity', International Journal of Molecular Sciences, 24(15), pp. 12044. doi:10.3390/ijms241512044 Preclinical
https://doi.org/10.3390/ijms241512044 - Moaca, E., Pavel, I.Z., Danciu, C., Crainiceanu, Z., Minda, D., Ardelean, F., Antal, D.S., Ghiulai, R., Cioca, A., Derban, M., Simu, S., Chioibas, R., Szuhanek, C. and Dehelean, C (2019) 'Romanian Wormwood (Artemisia absinthium L.): Physicochemical and Nutraceutical Screening', Molecules, 24(17), pp. 3087. doi:10.3390/molecules24173087 Preclinical
https://doi.org/10.3390/molecules24173087 - Turak, A., Shi, S., Jiang, Y. and Tu, P (2014) 'Dimeric guaianolides from Artemisia absinthium', Phytochemistry, 105, pp. 109-114. doi:10.1016/j.phytochem.2014.06.016 Preclinical
https://doi.org/10.1016/j.phytochem.2014.06.016 - Correa-Ferreira, M.L., Noleto, G.R. and Oliveira Petkowicz, C.L (2013) 'Artemisia absinthium and Artemisia vulgaris: a comparative study of infusion polysaccharides', Carbohydrate Polymers, 102, pp. 738-745. doi:10.1016/j.carbpol.2013.10.096 Preclinical
https://doi.org/10.1016/j.carbpol.2013.10.096 - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
https://scholar.google.com/scholar?q=Medical%20Herbalism - Lee, J.-Y. and Park, H. and Lim, W. and Song, G (2020) 'alpha,beta-Thujone suppresses human placental choriocarcinoma cells via metabolic disruption', Reproduction, 159(6), pp. 745-756. doi:10.1530/REP-20-0018 Preclinical
https://doi.org/10.1530/REP-20-0018 - He, M. and Yasin, K. and Yu, S. and Li, J. and Xia, L (2023) 'Total Flavonoids in Artemisia absinthium L. and Evaluation of Its Anticancer Activity', International Journal of Molecular Sciences, 24(22), pp. 16348. doi:10.3390/ijms242216348 Preclinical
https://doi.org/10.3390/ijms242216348 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Gulliver, W.P. and Donsky, H.J (2005) 'A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis', American Journal of Therapeutics, 12(5), pp. 398-406. doi:10.1097/01.mjt.0000174350.82270.da Clinical study
https://doi.org/10.1097/01.mjt.0000174350.82270.da - Cernakova, M. and Kostalova, D (2002) 'Antimicrobial activity of berberine--a constituent of Mahonia aquifolium', Folia Microbiologica, 47(4), pp. 375-378. doi:10.1007/BF02818693 Preclinical
https://doi.org/10.1007/BF02818693 - Damjanovic, A., Kolundzija, B., Matic, I.Z., Krivokuca, A. and others (2020) 'Mahonia aquifolium Extracts Promote Doxorubicin Effects against Lung Adenocarcinoma Cells In Vitro', Molecules, 25(22), pp. 5233. doi:10.3390/molecules25225233 Preclinical
https://doi.org/10.3390/molecules25225233 - Cernakova, M., Kostalova, D., Kettmann, V., Plodova, M. and others (2002) 'Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium', BMC Complementary and Alternative Medicine, 2, pp. 2. doi:10.1186/1472-6882-2-2 Preclinical
https://doi.org/10.1186/1472-6882-2-2 - Slobodnikova, L., Kostalova, D., Labudova, D., Kotulova, D. and Kettmann, V (2004) 'Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids', Phytotherapy Research, 18(8), pp. 674-676. doi:10.1002/ptr.1517 Preclinical
https://doi.org/10.1002/ptr.1517 - Godjevac, D., Damjanovic, A., Stanojkovic, T.P., Andjelkovic, B. and Zdunic, G (2018) 'Identification of cytotoxic metabolites from Mahonia aquifolium using 1H NMR-based metabolomics approach', Journal of Pharmaceutical and Biomedical Analysis, 150, pp. 9-14. doi:10.1016/j.jpba.2017.11.075 Preclinical
https://doi.org/10.1016/j.jpba.2017.11.075 - Muller, K. and Ziereis, K (1994) 'The antipsoriatic Mahonia aquifolium and its active constituents; I. Pro- and antioxidant properties and inhibition of 5-lipoxygenase', Planta Medica, 60(5), pp. 421-424. doi:10.1055/s-2006-959523 Preclinical
https://doi.org/10.1055/s-2006-959523 - Rohrer, U., Kunz, E.M.K., Lenkeit, K., Schaffner, W. and Meyer, J (2007) 'Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria', Schweizer Monatsschrift fur Zahnmedizin, 117(11), pp. 1126-1131. Preclinical
https://scholar.google.com/scholar?q=Antimicrobial%20activity%20of%20Mahonia%20aquifolium%20and%20two%20of%20its%20alkaloids%20against%20oral%20bacteria - Vollekova, A., Kostalova, D., Kettmann, V. and Toth, J (2003) 'Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids', Phytotherapy Research, 17(7), pp. 834-837. doi:10.1002/ptr.1256 Preclinical
https://doi.org/10.1002/ptr.1256 - Hajnicka, V., Kostalova, D., Svecova, D., Sochorova, R. and others (2002) 'Effect of Mahonia aquifolium active compounds on interleukin-8 production in the human monocytic cell line THP-1', Planta Medica, 68(3), pp. 266-268. doi:10.1055/s-2002-23126 Preclinical
https://doi.org/10.1055/s-2002-23126 - Gulliver, W.P. and colleagues (2018) 'Review of the Efficacy and Safety of Topical Mahonia aquifolium for the Treatment of Psoriasis and Atopic Dermatitis', Journal of Clinical and Aesthetic Dermatology. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ Meta-analysis / review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ - Herbal Reality (n.d.) 'Oregon Grape Root (Berberis aquifolium): Benefits, Uses, Safety'. Available at: https://www.herbalreality.com/herb/oregon-grape/ Traditional / reference
https://www.herbalreality.com/herb/oregon-grape/ - Bernstein, S., Donsky, H., Gulliver, W., Hamilton, D., Nobel, S. and Norman, R (2006) 'Treatment of mild to moderate psoriasis with Relieva, a Mahonia aquifolium extract - a double-blind, placebo-controlled study', American Journal of Therapeutics, 13(2), pp. 121--126. doi:10.1097/00045391-200603000-00007 Randomized trial
https://doi.org/10.1097/00045391-200603000-00007
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.